Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-16 4:32 pm Sale |
2020-12-31 | 13G | Protara Therapeutics, Inc. TARA |
Rock Springs Capital Management LP | 643,200 5.740% |
-422 (-0.07%) |
Filing History |
| 2021-02-16 3:38 pm Unchanged |
2020-12-31 | 13G | Protara Therapeutics, Inc. TARA |
Perceptive Advisors LLC | 608,544 5.400% |
0 (Unchanged) |
Filing History |
| 2021-02-12 4:31 pm Purchase |
2020-12-31 | 13G | Protara Therapeutics, Inc. TARA |
Ikarian Capital LLC | 649,542 5.800% |
649,542 (New Position) |
Filing History |
| 2021-01-08 3:32 pm Unchanged |
2021-01-05 | 13D | Protara Therapeutics, Inc. TARA |
Flynn James E | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2020-10-02 3:38 pm Purchase |
2020-09-22 | 13G | Protara Therapeutics, Inc. TARA |
Rock Springs Capital Management LP | 643,622 6.160% |
643,622 (New Position) |
Filing History |
| 2020-10-01 4:09 pm Purchase |
2020-09-24 | 13G | Protara Therapeutics, Inc. TARA |
Perceptive Advisors LLC | 608,544 5.800% |
608,544 (New Position) |
Filing History |
| 2020-09-25 5:20 pm Sale |
2020-09-24 | 13D | Protara Therapeutics, Inc. TARA |
Opaleye Management Inc. | 2,508,472 23.860% |
-2,527,538 (-50.19%) |
Filing History |